GlucoTrack, Inc. (GCTK) vs Sunshine Biopharma, Inc. (SBFM)
A side-by-side comparison of GlucoTrack, Inc. and Sunshine Biopharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GCTK
GlucoTrack, Inc.
$1.11HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
SBFM
Sunshine Biopharma, Inc.
$0.37HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
Total return — GCTK vs SBFM
growth of $100 · dividends reinvested · last 10yGCTK -100.0% (-74.0%/yr)SBFM -100.0% (-74.0%/yr)SBFM compounded faster over this window
GCTK SBFM
GCTK vs SBFM: by the numbers
- •GCTK is the larger company ($881948 vs $880215 market cap).
- •Both run net losses; GCTK's is the smaller (0.00% vs -16.50% net margin).
Metrics side by side
Valuation
| Metric | GCTK | SBFM |
|---|---|---|
| P/S ratio | N/A | 0.02 |
| P/B ratio | N/A | 0.03 |
Profitability
| Metric | GCTK | SBFM |
|---|---|---|
| Gross margin | 0.00% | 29.80% |
| Operating margin | 0.00% | -14.71% |
| Net margin | 0.00% | -16.50% |
| ROE | N/A | -21.18% |
| ROIC | N/A | -18.56% |
Growth (annualized)
| Metric | GCTK | SBFM |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 203.18% |
| Total return CAGR (5Y) | -92.60% | N/A |
Go deeper
Dig into the metrics
GlucoTrack ROESunshine Biopharma ROEGlucoTrack operating marginSunshine Biopharma operating marginGlucoTrack revenue growthSunshine Biopharma revenue growthGlucoTrack free cash flowSunshine Biopharma free cash flow
GlucoTrack & Sunshine Biopharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.